This inventor holds 9 USPTO granted patents and 2 EPO patents. Top assignees: Boehringer Ingelheim (Canada) Ltd., Boehringer Ingelheim International Gmbh. Active years: 2002-2010.
Location History:
- Montréal, CA (2002)
- Laval, CA (2004 - 2006)
- Montreal, CA (2004 - 2010)
Company Filing History:
8 out of 62 
1 out of 1,560 
Years Active: 2002-2010
Title: The Innovative Contributions of Peter White
Introduction
Peter White is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medical research, particularly in the development of compounds aimed at inhibiting the papilloma virus. With a total of 9 patents to his name, White's work has the potential to impact the treatment and prevention of viral infections.
Latest Patents
Among his latest patents, White has developed inhibitors of the papilloma virus. One of his notable inventions includes a compound of formula (I) or its enantiomers or diastereoisomers, which can be used as inhibitors of the papilloma virus E1-E2-DNA complex. This invention provides a method for treating or preventing human papilloma virus infections. Another significant patent involves the use of a compound of formula (II) for the treatment or prevention of papilloma virus infections, particularly in mammals. This invention also introduces novel compounds and pharmaceutical compositions that can inhibit papilloma virus DNA replication by interfering with essential protein-protein interactions.
Career Highlights
Peter White has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim (Canada) Ltd. and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in developing innovative solutions for viral infections.
Collaborations
Throughout his career, White has collaborated with talented individuals such as Christiane Yoakim and Jeffrey O'Meara. These partnerships have likely enhanced his research and development efforts in the field of virology.
Conclusion
Peter White's innovative work in developing inhibitors for the papilloma virus showcases his dedication to advancing medical science. His contributions have the potential to significantly improve treatment options for viral infections.